SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-021953
Filing Date
2023-08-03
Accepted
2023-08-03 16:20:02
Documents
14
Period of Report
2023-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20230506_8k.htm   iXBRL 8-K 29953
2 EXHIBIT 99.1_ITEM 2.02 FINANCIAL RESULTS ex_554340.htm EX-99.1 94172
  Complete submission text file 0001437749-23-021953.txt   267043

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20230803.xsd EX-101.SCH 3408
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20230803_def.xml EX-101.DEF 11423
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20230803_lab.xml EX-101.LAB 15309
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20230803_pre.xml EX-101.PRE 11583
8 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20230506_8k_htm.xml XML 2576
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 231140365
SIC: 2836 Biological Products, (No Diagnostic Substances)